Interval cancers after colonoscopy-insights and recommendations

Nature Reviews Gastroenterology and Hepatology

Volumn 9, Issue 9, 2012, Pages 550-554

  Sanduleanu, Silvia ^a   Masclee, Ad M ^a   Meijer, Gerrit A ^b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GROWTH; CANCER INCIDENCE; CANCER PREVENTION; CANCER SCREENING; CLINICAL EFFECTIVENESS; COLON POLYP; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; COMORBIDITY; HUMAN; INTERVAL COLORECTAL CANCER; MONITORING; POLYPECTOMY; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

COLONOSCOPY; COLORECTAL NEOPLASMS; EPIDEMIOLOGICAL MONITORING; HUMANS; INCIDENCE; TIME FACTORS;

EID: 84865803293     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2012.136     Document Type: Review

References (53)

1. Lakoff, J., Paszat, L. F., Saskin, R. & Rabeneck, L. Risk of developing proximal versus distal colorectal cancer after a negative colonoscopy: a population-based study. Clin. Gastroenterol. Hepatol. 6, 1117-1121 (2008).
2. Brenner, H., Chang-Claude, J., Seiler, C. M., Rickert, A. & Hoffmeister, M. Protection from colorectal cancer after colonoscopy: a population-based, case-control study. Ann. Intern. Med. 154, 22-30 (2011).
3. Singh, H., Nugent, Z., Demers, A. A. & Bernstein, C. N. Rate and predictors of early/missed colorectal cancers after colonoscopy in manitoba: a population-based study. Am. J. Gastroenterol. 105, 2588-2596 (2010).
4. Baxter, N. N. et al. Association of colonoscopy and death from colorectal cancer. Ann. Intern. Med. 150, 1-8 (2009).
5. Rex, D. K. Preventing colorectal cancer and cancer mortality with colonoscopy: what we know and what we don't know. Endoscopy 42, 320-323 (2010).
6. Rex, D. K., Bond, J. H. & Feld, A. D. Medical-legal risks of incident cancers after clearing colonoscopy. Am. J. Gastroenterol. 96, 952-957 (2001). (Pubitemid 32319122)
7. Kaminski, M. F. et al. Quality indicators for colonoscopy and the risk of interval cancer. N. Engl. J. Med. 362, 1795-1803 (2010).
8. le Clercq, C. et al. Interval colorectal cancers frequently have subtle macroscopic appearance: a 10 year-experience in an academic center. Gastroenterology 140, S112-S113 (2011).
9. Baxter, N. N. et al. Analysis of administrative data finds endoscopist quality measures associated with postcolonoscopy colorectal cancer. Gastroenterology 140, 65-72 (2011).
10. Imperiale, T. F. et al. Five-year risk of colorectal neoplasia after negative screening colonoscopy. N. Engl. J. Med. 359, 1218-1224 (2008).
11. Bressler, B. et al. Rates of new or missed colorectal cancers after colonoscopy and their risk factors: a population-based analysis. Gastroenterology 132, 96-102 (2007). (Pubitemid 46108740)
12. Rabeneck, L., Paszat, L. F. & Saskin, R. Endoscopist specialty is associated with incident colorectal cancer after a negative colonoscopy. Clin. Gastroenterol. Hepatol. 8, 275-279 (2010).
13. Ferlay, J., Parkin, D. M. & Steliarova-Foucher, E. Estimates of cancer incidence and mortality in Europe in 2008. Eur. J. Cancer 46, 765-781 (2010).
14. Gorski, T. F., Rosen, L., Riether, R., Stasik, J. & Khubchandani, I. Colorectal cancer after surveillance colonoscopy: false-negative examination or fast growth? Dis. Colon Rectum 42, 877-880 (1999). (Pubitemid 29328457)
15. Haseman, J. H., Lemmel, G. T., Rahmani, E. Y. & Rex, D. K. Failure of colonoscopy to detect colorectal cancer: evaluation of 47 cases in 20 hospitals. Gastrointest. Endosc. 45, 451-455 (1997). (Pubitemid 27424393)
16. Chen, S. C. & Rex, D. K. Endoscopist can be more powerful than age and male gender in predicting adenoma detection at colonoscopy. Am. J. Gastroenterol. 102, 856-861 (2007). (Pubitemid 46496608)
17. Robertson, D. J. et al. Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterology 129, 34-41 (2005). (Pubitemid 41002040)
18. Farrar, W. D., Sawhney, M. S., Nelson, D. B., Lederle, F. A. & Bond, J. H. Colorectal cancers found after a complete colonoscopy. Clin. Gastroenterol. Hepatol. 4, 1259-1264 (2006). (Pubitemid 44512220)
19. Kahi, C. J., Hewett, D. G. & Rex, D. K. Relationship of non-polypoid colorectal neoplasms to quality of colonoscopy. Gastrointest. Endosc. Clin. N. Am. 20, 407-415 (2010).
20. Martinez, M. E. et al. A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroenterology 136, 832-841 (2009).
21. Morini, S. et al. Diverticular disease as a risk factor for sigmoid colon adenomas. Dig. Liver Dis. 34, 635-639 (2002).
22. Leung, K. et al. Ongoing colorectal cancer risk despite surveillance colonoscopy: the Polyp Prevention Trial Continued Follow-up Study. Gastrointest. Endosc. 71, 111-117 (2010).
23. Loeve, F., van Ballegooijen, M., Snel, P. & Habbema, J. D. Colorectal cancer risk after colonoscopic polypectomy: a population-based study and literature search. Eur. J. Cancer 41, 416-422 (2005). (Pubitemid 40192530)
24. Imperiale, T. F., Glowinski, E. A., Juliar, B. E., Azzouz, F. & Ransohoff, D. F. Variation in polyp detection rates at screening colonoscopy. Gastrointest. Endosc. 69, 1288-1295 (2009).
25. Arain, M. A. et al. CIMP status of interval colon cancers: another piece to the puzzle. Am. J. Gastroenterol. 105, 1189-1195 (2009).
26. Hewett, D. G., Kahi, C. J. & Rex, D. K. Efficacy and effectiveness of colonoscopy: how do we bridge the gap? Gastrointest. Endosc. Clin. N. Am. 20, 673-684 (2010).
27. Barclay, R. L., Vicari, J. J., Doughty, A. S., Johanson, J. F. & Greenlaw, R. L. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. N. Engl. J. Med. 355, 2533-2541 (2006). (Pubitemid 44917501)
28. Lee, R. H. et al. Quality of colonoscopy withdrawal technique and variability in adenoma detection rates (with videos). Gastrointest. Endosc. 74, 128-134 (2011).
29. Rex, D. K. Looking over your shoulder during colonoscopy: potential roles for videorecording colonoscopy withdrawals. Gastrointest. Endosc. 75, 134-137 (2012).
30. Pabby, A. et al. Analysis of colorectal cancer occurrence during surveillance colonoscopy in the dietary Polyp Prevention Trial. Gastrointest. Endosc. 61, 385-391 (2005). (Pubitemid 40349030)
31. Atkin, W. S., Morson, B. C. & Cuzick, J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N. Engl. J. Med. 326, 658-662 (1992).
32. Sawhney, M. S. et al. Microsatellite instability in interval colon cancers. Gastroenterology 131, 1700-1705 (2006). (Pubitemid 44958526)
33. Shaukat, A., Arain, M., Thaygarajan, B., Bond, J. H. & Sawhney, M. Is BRAF mutation associated with interval colorectal cancers? Dig. Dis. Sci. 55, 2352-2356 (2010).
34. Gervaz, P., Bucher, P. & Morel, P. Two colons-two cancers: paradigm shift and clinical implications. J. Surg. Oncol. 88, 261-266 (2004). (Pubitemid 39601269)
35. Iacopetta, B. Are there two sides to colorectal cancer? Int. J. Cancer 101, 403-408 (2002).
36. Li, F. Y. & Lai, M. D. Colorectal cancer, one entity or three. J. Zhejiang Univ. Sci. B 10, 219-229 (2009).
37. Soetikno, R. M. et al. Prevalence of nonpolypoid (flat and depressed) colorectal neoplasms in asymptomatic and symptomatic adults. JAMA 299, 1027-1035 (2008). (Pubitemid 351347059)
38. Soetikno, R. M., Gotoda, T., Nakanishi, Y. & Soehendra, N. Endoscopic submucosal resection. Gastrointest. Endosc. 57, 5675-5679 (2003).
39. Konishi, K. et al. BRAF mutations and phosphorylation status of mitogen-activated protein kinases in the development of flat and depressed-type colorectal neoplasias. Br. J. Cancer 94, 311-317 (2006). (Pubitemid 43151553)
40. Matsuda, T., Saito, Y., Hotta, K., Sano, Y. & Fujii, T. Prevalence and clinicopathological features of nonpolypoid colorectal neoplasms: should we pay more attention to identifying flat and depressed lesions? Dig. Endosc. 22 (Suppl. 1), S57-S62 (2010).
41. Rondagh, E. J. et al. Endoscopic appearance of proximal colorectal neoplasms and potential implications for colonoscopic cancer prevention. Gastrointest. Endosc. 75, 1218-1225 (2012).
42. Snover, D. C. Update on the serrated pathway to colorectal carcinoma. Hum. Pathol. 42, 1-10 (2011).
43. Rondagh, E. J. et al. Endoscopic red flags for the detection of high-risk serrated polyps: an observational study. Endoscopy 43, 1052-1058 (2011).
44. Sweetser, S., Smyrk, T. C. & Sugumar, A. Serrated polyps: critical precursors to colorectal cancer. Expert Rev. Gastroenterol. Hepatol. 5, 627-635 (2011).
45. Kahi, C. J., Hewett, D. G., Norton, D. L., Eckert, G. J. & Rex, D. K. Prevalence and variable detection of proximal colon serrated polyps during screening colonoscopy. Clin. Gastroenterol. Hepatol. 9, 42-46 (2011).
46. Hetzel, J. T. et al. Variation in the detection of serrated polyps in an average risk colorectal cancer screening cohort. Am. J. Gastroenterol. 105, 2656-2664 (2010).
47. Participants in the Paris Workshop. The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest. Endosc. 58, S3-S43 (2003).
48. Lasisi, F. & Rex, D. K. Improving protection against proximal colon cancer by colonoscopy. Expert Rev. Gastroenterol. Hepatol. 5, 745-754 (2011).
49. Jass, J. R. et al. Neoplastic progression occurs through mutator pathways in hyperplastic polyposis of the colorectum. Gut 47, 43-49 (2000). (Pubitemid 30430410)
50. East, J. E., Saunders, B. P. & Jass, J. R. Sporadic and syndromic hyperplastic polyps and serrated adenomas of the colon: classification, molecular genetics, natural history, and clinical management. Gastroenterol. Clin. North Am. 37, 25-46 (2008). (Pubitemid 351289032)
51. Sillars-Hardebol, A. H., Carvalho, B., van Engeland, M., Fijneman, R. J. & Meijer, G. A. The adenoma hunt in colorectal cancer screening: defining the target. J. Pathol. 226, 1-6 (2012).
52. Mulder, S. A. et al. Exposure to colorectal examinations before a colorectal cancer diagnosis: a case-control study. Eur. J. Gastroenterol. Hepatol. 22, 437-443 (2010).
53. Kahi, C. J., Imperiale, T. F., Juliar, B. E. & Rex, D. K. Effect of screening colonoscopy on colorectal cancer incidence and mortality. Clin. Gastroenterol. Hepatol 7, 770-775 (2009).